| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/08/2008 | US7355000 PRO1380 polypeptides |
| 04/08/2008 | US7354998 PRO7171 polypeptides |
| 04/08/2008 | US7354997 Polypeptide encoded by a nucleic acid underexpressed in stomach tumor |
| 04/08/2008 | US7354994 Recombinant IGF expression systems |
| 04/08/2008 | US7354992 Expression vectors, eukaryotic and prokaryotic cell lines; cancer vaccines |
| 04/08/2008 | US7354991 Heptapeptides having the natural binding site for autoantibodies found in elevated levels in schizophrenics binds to serum sample obtained from a schizophrenic patient at a substantively higher level than its binding to a body fluid sample obtained from a non-schizophrenic individual; diagnosis kits |
| 04/08/2008 | US7354903 For skin care; 5-23 amino acids in length and >/= 50% phenylalanine, leucine, alanine, and lysine residues; microbiocides, fungicides, and anticancer agents |
| 04/08/2008 | US7354902 Comprises nucleotide sequence coding genetically engineered transferrin for use in cosmetic and cancer diagnostics; antiinflammatory agents; viricides; bactericides |
| 04/08/2008 | US7354901 Production of recombinant BMP-2 |
| 04/08/2008 | US7354899 Treating autoimmune diseases such as multiple sclerosis with CXCR4 antagonist such as peptides having of stromal cell derived factor one (SDF-1) sequences |
| 04/08/2008 | US7354898 Identifying agents which modify mitogen activated kinase activities associated with cell death; small interfering RNA and treament of cell proliferative disorders; for modulating diseases and conditions associated with elevated or decreased apoptosis |
| 04/08/2008 | US7354896 Suspension containing milk fat spheres; therapy for infant weight diseases |
| 04/08/2008 | US7354769 Comparing the ability of N,N-bis(3-D-gluconamidopropyl)-deoxycholamine to inhibit binding of IGFBP-1 or -3 to IGF-1 with the ability of a candidate indirect agonist of IGF-1 to identify effective agonists |
| 04/08/2008 | US7354762 Transfecting with an expression vector containing DNA construct encoding chimeric receptor; electroporation; use in immunotherapy and treatment of neuroblastoma |
| 04/08/2008 | US7354761 Yeast cells; ribonuclease barnase marker gene; libraries; drug resistance |
| 04/08/2008 | US7354760 Expression of protective antigens in transgenic chloroplasts |
| 04/08/2008 | US7354756 Expression of nucleic acid produces polypeptide which spontaneously splices in host to yield a cyclized form; catalyzes formation of aminosuccinimide; useful in drug screening |
| 04/08/2008 | US7354740 Animal product free system and process for purifying a botulinum toxin |
| 04/08/2008 | US7354739 Modulation contraction of stomach tissue; gastrointestinal disorders; applying peptide |
| 04/08/2008 | US7354738 isolated polypeptide modulates activity of nuclear receptor/ nuclear respiratory factor, brown adipose cell determination/differentiation, mitochondrial activity, biogenesis, fatty acid oxidation |
| 04/08/2008 | US7354737 peptide delivers biological response modifiers into cytoplasm, intracellular organelles or nucleus of prokaryotic/eukaryotic cells; use in drug delivery, vaccines, gene and protein therapy |
| 04/08/2008 | US7354736 Intracellular caspase inhibitory polypeptide for use in treatment and prevention of cell proliferative, nervous system and autoimmune disorders |
| 04/08/2008 | US7354728 Coactivation of nuclear receptors |
| 04/08/2008 | US7354726 Identifying modulators of g protein coupled receptor activity for diagnosing, treating and preventing disorders associated with cholesterol metabolism, cancer, infections and inflammation |
| 04/08/2008 | US7354724 Drosophila G protein coupled receptors, nucleic acids, and methods related to the same |
| 04/08/2008 | US7354709 Diagnosing cancer in mammals; obtain sample cells, monitor expression of collapsin protein, amplified concentration of collapsin indicates cancer |
| 04/08/2008 | US7354594 Merozoite surface protein 1 lacking glycosylation sites |
| 04/08/2008 | US7354592 Administering mutant Salmonella sp. for therapy of solid tumor cancer, disrupted msbB gene and is capable of targeting a solid tumor cancer |
| 04/08/2008 | US7354591 Poxvirus with targeted infection specificity |
| 04/08/2008 | US7354588 Organ transplantation, tissue grafting, allergy, oncology, diagnosis, therapy |
| 04/08/2008 | US7354586 Treating arthritis by administering a therapeutically effective amount of an antibody immunospecific for av beta 3; antiarthritic agents;anticarcinogenic agents; antitumor agents; antimetastasis agents; antiinflammatory agents; antibody does not immunoreact with integrins other than av beta 3 |
| 04/08/2008 | US7354583 Antibody-induced apoptosis |
| 04/08/2008 | US7354582 Use of VEGF antagonists for the treatment of malignant gliomas |
| 04/08/2008 | US7354581 For treating a disease or condition related to angiogenesis |
| 04/08/2008 | US7354580 Method of administering and using VEGF inhibitors for the treatment of human cancer |
| 04/08/2008 | US7354579 Method of treating cancer with a VEGF antagonist and an anti-proliferative agent |
| 04/08/2008 | US7354578 Method of tumor regression with VEGF inhibitors |
| 04/08/2008 | US7354577 Common lymphatic endothelial and vascular endothelial receptor-1 (CLEVER-1) and uses thereof |
| 04/08/2008 | CA2305013C Fusion proteins comprising hiv-1 tat and/or nef proteins |
| 04/08/2008 | CA2295588C Nanocrystalline formulations of human immunodeficiency virus (hiv) protease inhibitors using cellulosic surface stabilizers and methods of making such formulations |
| 04/08/2008 | CA2259632C A method for chromatographic removal of prions |
| 04/08/2008 | CA2253838C Dp and e2f protein nuclear localisation signals and their use |
| 04/08/2008 | CA2169171C New growth/differentiation factor of the tgf-beta family |
| 04/08/2008 | CA2143104C Phagemids coexpressing a surface receptor and a surface heterologous protein |
| 04/08/2008 | CA2136564C Process for producing human serum albumin |
| 04/08/2008 | CA2130454C Production of viral resistant plants via introduction of untranslatable plus sense viral rna |
| 04/08/2008 | CA2111006C A novel receptor-type tyrosine kinase and use thereof |
| 04/03/2008 | WO2008039909A1 Genetic modification of targeted regions of the cardiac conduction system |
| 04/03/2008 | WO2008039843A2 Novel peptides that promote lipid efflux |
| 04/03/2008 | WO2008039838A2 Synthetic streptococcus pneumoniae vaccine |
| 04/03/2008 | WO2008039818A2 Modified t cell receptors and related materials and methods |
| 04/03/2008 | WO2008039553A1 Soluble il-17rcx4 and methods of using in inflammation |
| 04/03/2008 | WO2008039415A2 Analogs of ghrelin substituted at the n-terminal |
| 04/03/2008 | WO2008039367A1 Synthesis of trans-tert-butyl-2-aminocyclopentylcarbamate |
| 04/03/2008 | WO2008039361A2 Method for enhancing immune responses in mammals |
| 04/03/2008 | WO2008039141A1 Chromatography ligand comprising domain c from staphyloccocus aureus protein a for antibody isolation |
| 04/03/2008 | WO2008038766A1 Functional peptide having activity of stimulating immune cell |
| 04/03/2008 | WO2008038296A2 Recombinant calcitonin fused to interleukin-2 |
| 04/03/2008 | WO2008038287A2 N-terminal fgf variants having increased receptor selectivity and uses thereof |
| 04/03/2008 | WO2008038153A2 Proteins recruited by virus during infection of plants and method for their isolation and identification |
| 04/03/2008 | WO2008038138A1 Optimal method for recombinant production of a marine metalloprotein and uses thereof |
| 04/03/2008 | WO2008037943A1 Cells transformed with nucleic acid encoding ny-eso t cell receptors |
| 04/03/2008 | WO2008037792A1 Novel antigens and antibodies associated to pancreatic ductal adenocarcinoma |
| 04/03/2008 | WO2008037735A1 Method for making maturated insulin polypeptides |
| 04/03/2008 | WO2008037504A1 Interleukin-1 muteins linked to virus-like particles to treat il-1 associated diseases |
| 04/03/2008 | WO2008037436A1 Methods and means for removal of a selected dna sequence |
| 04/03/2008 | WO2008037431A1 Transcriptional repressors of cytokinin signaling and their use |
| 04/03/2008 | WO2008037080A1 Methods and compositions for immune response modulation and uses thereof |
| 04/03/2008 | WO2008037043A1 The process of production and purification of recombinant gp43 (rgp43) isoforms in the yeast pichia pastoris, use of rgp43 and diagnostic kit |
| 04/03/2008 | WO2008037028A1 Tropoelastin-based protoelastin biomaterials |
| 04/03/2008 | WO2008022302A3 Immunogenic pcpa polypeptides and uses thereof |
| 04/03/2008 | WO2008022298A3 Immunogenic pcpa polypeptides and uses thereof |
| 04/03/2008 | WO2008020293A3 West nile virus envelope (e) protein antigen and immunoassay |
| 04/03/2008 | WO2008018642A3 Genes and polypeptides relating to breast cancers |
| 04/03/2008 | WO2008013454A3 Immunogenic compounds and protein mimics |
| 04/03/2008 | WO2008012045A3 Regulation of interleukin-23 |
| 04/03/2008 | WO2008010088A3 Cd4 mimic peptides and their uses |
| 04/03/2008 | WO2008006734A3 Uv-sensitive safety stems for biotechnological production |
| 04/03/2008 | WO2008002153A3 Novel polypeptides |
| 04/03/2008 | WO2007145956A3 USE OF TGF-β ANTAGONISTS IN TREATMENT OF PARATHYROID-RELATED DISORDERS |
| 04/03/2008 | WO2007141346A3 Genes regulating intracellular cholesterol trafficking as targets for treatment of cholesterol-related diseases |
| 04/03/2008 | WO2007133811A3 Cd47 related compositions and methods for treating immunological diseases and disorders |
| 04/03/2008 | WO2007131092A3 Chimeric t cell receptors and related materials and methods of use |
| 04/03/2008 | WO2007130302A3 Rage fusion proteins, formulations, and methods of use thereof |
| 04/03/2008 | WO2007128545A3 Mac30 gene |
| 04/03/2008 | WO2007123791A9 Methods of determining cellular chemosensitivity |
| 04/03/2008 | WO2007109135A3 Neuromedin u receptor agonists and uses thereof |
| 04/03/2008 | WO2007103515A3 Unstructured recombinant polymers and uses thereof |
| 04/03/2008 | WO2007093849A3 P100 bacteriophage for control of listeria monocytogenes |
| 04/03/2008 | WO2007081447A3 Norovirus and sapovirus antigens |
| 04/03/2008 | WO2007076302A3 High throughput assay for modulators of peptidylarginine deiminase activity |
| 04/03/2008 | WO2007076032A3 Compositions and methods for producing a composition |
| 04/03/2008 | WO2007067683A3 Methods and compositions for expanding t regulatory cells |
| 04/03/2008 | US20080081903 Method for screening transcriptional coregulatory proteins of transcription factors, and androgen receptor transcriptional coregulatory proteins as targets for androgen receptor-dependent diseases |
| 04/03/2008 | US20080081901 Alpha-conotoxin peptides |
| 04/03/2008 | US20080081841 Materials and Methods for Modulating Cell Motility |
| 04/03/2008 | US20080081794 Smg-1 binding protein and screening method for substances that can regulate the activity thereof |
| 04/03/2008 | US20080081787 stable aqueous solution containing endogenous growth hormone secretagogues having pH range of 2 to 7; a pH adjuster or a buffer agent; nondegradation, storage stability; biodrug inducing the secretion of growth hormone |
| 04/03/2008 | US20080081785 Paralytic Peptide For Use In Neuromuscular Therapy |
| 04/03/2008 | US20080081784 Administering to the cell a peptide isolated from the submaxiliary saliva glands of shrews of the species Blarina as a paralytic agent for reducing wrinkles; inhibits calcium uptake |